Anhedonia in Parkinson's disease patients with and without pathological gambling: A case-control study

Psychiatry Research

Volumn 215, Issue 2, 2014, Pages 448-452

  Pettorruso, Mauro ^a   Martinotti, Giovanni ^b   Fasano, Alfonso ^c   Loria, Giovanna ^a   Di Nicola, Marco ^a   De Risio, Luisa ^a   Ricciardi, Lucia ^a   Conte, Gianluigi ^a   Janiri, Luigi ^a   Bentivoglio, Anna Rita ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Addictive behaviors; Dopamine replacement therapy; Frontal function impairment; Hedonic tone; Impulse control disorders; Impulsivity traits; Reward system

Indexed keywords

ADDICTION; ADULT; AGED; ANHEDONIA; ARTICLE; BARRATT IMPULSIVENESS SCALE; BINGE EATING DISORDER; CASE CONTROL STUDY; CLINICAL ASSESSMENT; COMORBIDITY; COMPULSION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MODEL; FEMALE; HABITUATION; HUMAN; HYPERSEXUALITY; IMPULSE CONTROL DISORDER; IMPULSIVENESS; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; PATHOLOGICAL GAMBLING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; REWARD; COMPLICATION; GAMBLING; MIDDLE AGED; PLEASURE; PSYCHOLOGY;

AGED; ANHEDONIA; BEHAVIOR, ADDICTIVE; CASE-CONTROL STUDIES; COMPULSIVE BEHAVIOR; FEMALE; GAMBLING; HUMANS; IMPULSE CONTROL DISORDERS; MALE; MIDDLE AGED; PARKINSON DISEASE; PLEASURE; REWARD;

EID: 84893736440     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2013.12.013     Document Type: Article

References (69)

1. Ahmed S.H., Koob G.F. Transition from moderate to excessive drug intake: change in hedonic set point. Science 1998, 282:298-300.
2. Diagnostic and statiStical Manual of Mental Disorders 2000, American Psychiatric Association, Author, Washington, DC, (text rev.). 4th ed.
3. Antonini A., Siri C., Santangelo G., Cilia R., Poletti M., Canesi M., Caporali A., Mancini F., Pezzoli G., Ceravolo R., Bonuccelli U., Barone P. Impulsivity and compulsivity in drug-naïve patients with Parkinson's disease. Movement Disorders 2011, 26:464-468.
4. Assogna F., Cravello L., Caltagirone C., Spalletta G. Anhedonia in Parkinson's disease: a systematic review of the literature. Movement Disorders 2011, 26:1825-1834.
5. Bentivoglio A.R., Baldonero E., Ricciardi L., De Nigris F., Daniele A. Neuropsychological features of patients with Parkinson's disease and impulse control disorders. Neurological Sciences 2013, 34:1207-1213. 10.1007/s10072-012-1224-5.
6. Braak H., Braak E. Pathoanatomy of Parkinson's disease. Journal of Neurology 2000, 247(Suppl. 2):S3-S10.
7. Brown R.M., Lawrence A.J. Compulsive use of dopamine replacement therapy in Parkinson's disease: insights into the neurobiology of addiction. Addiction 2012, 107:250-251.
8. Cilia R., Ko J.H., Cho S.S., van Eimeren T., Marotta G., Pellecchia G., Pezzoli G., Antonini A., Strafella A.P. Reduced dopamine transporter density in the ventral striatum of patients with Parkinson's disease and pathological gambling. Neurobiology of Disease 2010, 39:98-104.
9. Dalley J.W., Fryer T.D., Brichard L., Robinson E.S., Theobald D.E., Lääne K., Peña Y., Murphy E.R., Shah Y., Probst K., Abakumova I., Aigbirhio F.I., Richards H.K., Hong Y., Baron J.C., Everitt B.J., Robbins T.W. Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science 2007, 315:1267-1270.
10. Di Giannantonio M., Di Iorio G., Guglielmo R., De Berardis D., Conti C.M., Acciavatti T., Cornelio M., Martinotti G. Major depressive disorder, anhedonia and agomelatine: an open-label study. Journal of Biological Regulators and Homeostatic Agents 2011, 25:109-114.
11. Di Nicola M., De Risio L., Battaglia C., Camardese G., Tedeschi D., Martinotti G., Mazza M., Pozzi G., Niolu C., Di Giannantonio M., Siracusano A., Janiri L. Reduced hedonic capacity in euthymic bipolar subjects: a trait-like features?. Journal of Affective Disorder 2013, 147:446-450.
12. Di Nicola M., Tedeschi D., Mazza M., Martinotti G., Harnic D., Catalano V., Bruschi A., Pozzi G., Bria P., Janiri L. Behavioural addictions in bipolar disorder patients: role of impulsivity and personality dimensions. Journal of Affective Disorders 2010, 125:82-88.
13. Djamshidian A., Cardoso F., Grosset D., Bowden-Jones H., Lees A.J. Pathological gambling in Parkinson's disease-a review of the literature. Movement Disorders 2011, 26:1976-1984.
14. Dubois B., Slachevsky A., Litvan I., Pillon B. The FAB: a Frontal Assessment Battery at bedside. Neurology 2000, 55:1621-1626.
15. Eagle D.M., Baunez C. Is there an inhibitory-response-control system in the rat? Evidence from anatomical and pharmacological studies of behavioral inhibition. Neuroscience and Biobehavioral Reviews 2010, 34:50-72.
16. Emre M., Aarsland D., Brown R., Burn D.J., Duyckaerts C., Mizuno Y., Broe G.A., Cummings J., Dickson D.W., Gauthier S., Goldman J., Goetz C., Korczyn A., Lees A., Levy R., Litvan I., McKeith I., Olanow W., Poewe W., Quinn N., Sampaio C., Tolosa E., Dubois B. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Movement Disorders 2007, 22:1689-1707.
17. Everitt B.J., Belin D., Economidou D., Pelloux Y., Dalley J.W., Robbins T.W. Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction. Philosophical Transactions of the Royal Society B: Biological Sciences 2008, 363:3125-3135.
18. Fasano A., Petrovic I. Insights into pathophysiology of punding reveal possible treatment strategies. Molecular Psychiatry 2010, 15:560-573.
19. Fasano A., Pettorruso M., Ricciardi L., Conte G., Bentivoglio A.R. Punding in Parkinson's disease: the impact of patient's awareness on diagnosis. Movement Disorders 2010, 25:1297-1299.
20. Fasano A., Ricciardi L., Pettorruso M., Bentivoglio A.R. Management of punding in Parkinson's disease: an open-label prospective study. Journal of Neurology 2011, 258:656-660.
21. Fossati A., Di Ceglie A., Acquarini E., Barratt E.S. Psychometric properties of an Italian version of the Barratt Impulsiveness Scale-11 (BIS-11) in nonclinical subjects. Journal of Clinical Psychology 2001, 57:815-828.
22. Gelb D.J., Oliver E., Gilman S. Diagnostic criteria for Parkinson disease. Archives of Neurology 1999, 56:33-39.
23. Giovannoni G., O'Sullivan J.D., Turner K., Manson A.J., Lees A.J. Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies. Journal of Neurology, Neurosurgery and Psychiatry 2000, 68:423-428.
24. Goodman A. Neurobiology of addiction. An integrative review. Biochemical Pharmacology 2008, 75:266-322.
25. Hamilton M. The assessment of anxiety states by rating. British Journal of Medical Psychology 1959, 32:50-55.
26. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 1960, 23:56-62.
27. Hatzigiakoumis D.S., Martinotti G., Giannantonio M.D., Janiri L. Anhedonia and substance dependence: clinical correlates and treatment options. Frontiers in Psychiatry 2011, 2:10.
28. Housden C.R., O'Sullivan S.S., Joyce E.M., Lees A.J., Roiser J.P. Intact reward learning but elevated delay discounting in Parkinson's disease patients with impulsive-compulsive spectrum behaviors. Neuropsychopharmacology 2010, 35:2155-2164.
29. Hyman S.E., Malenka R.C., Nestler E.J. Neural mechanisms of addiction: the role of reward-related learning and memory. Annual Review of Neuroscience 2006, 29:565-598.
30. Isaias I.U., Siri C., Cilia R., De Gaspari D., Pezzoli G., Antonini A. The relationship between impulsivity and impulse control disorders in Parkinson's disease. Movement Disorders 2008, 23:411-415.
31. Isella V., Iurlaro S., Piolti R., Ferrarese C., Frattola L., Appollonio I., Melzi P., Grimaldi M. Physical anhedonia in Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry 2003, 74:1308-1311.
32. Jay T.M. Dopamine: a potential substrate for synaptic plasticity and memory mechanisms. Progress in Neurobiology 2003, 69:375-390.
33. Jentsch J.D., Taylor J.R. Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology (Berl) 1999, 146:373-390.
34. Koob G.F., Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 2001, 24:97-129.
35. Kranz G.S., Kasper S., Lanzenberger R. Reward and the serotonergic system. Neuroscience 2010, 166:1023-1035.
36. Lemke M.R., Brecht H.M., Koester J., Reichmann H. Effects of the dopamine agonist pramipexole on depression, anhedonia and motor functioning in Parkinson's disease. Journal of the Neurological Sciences 2006, 248:266-270.
37. Loas G., Krystkowiak P., Godefroy O. Anhedonia in Parkinson's disease: an overview. Journal of Neuropsychiatry and Clinical Neurosciences 2012, 24:444-451. 10.1176/appi.neuropsych.11110332.
38. Lobo D.S., Kennedy J.L. Genetic aspects of pathological gambling: a complex disorder with shared genetic vulnerabilities. Addiction 2009, 104:1454-1465.
39. Maclaren V.V., Fugelsang J.A., Harrigan K.A., Dixon M.J. The personality of pathological gamblers: a meta-analysis. Clinical Psychology Review 2011, 31:1057-1067.
40. Martinotti G., Andreoli S., Reina D., Di Nicola M., Ortolani I., Tedeschi D., Fanella F., Pozzi G., Iannoni E., D'Iddio S., Prof L.J. Acetyl-l-Carnitine in the treatment of anhedonia, melancholic and negative symptoms in alcohol dependent subjects. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2011, 35:953-958.
41. Martinotti G., Cloninger C.R., Janiri L. Temperament and character inventory dimensions and anhedonia in detoxified substance-dependent subjects. The American Journal of Drug and Alcohol Abuse 2008, 34:177-183.
42. Martinotti G., Di Nicola M., Reina D., Andreoli S., Focà F., Cunniff A., Tonioni F., Bria P., Janiri L. Alcohol protracted withdrawal syndrome: the role of anhedonia. Substance Use and Misuse 2008, 43:271-284.
43. Martinotti G., Sepede G., Gambi F., Di Iorio G., De Berardis D., Di Nicola M., Onofrj M., Janiri L., Di Giannantonio M. Agomelatine versus venlafaxine XR in the treatment of anhedonia in major depressive disorder: a pilot study. Journal of Clinical Psychopharmacology 2012, 32:487-491.
44. McElroy S.L., Keck P.E., Pope H.G., Smith J.M., Strakowski S.M. Compulsive buying: a report of 20 cases. Journal of Clinical Psychiatry 1994, 55:242-248.
45. Neikrug A.B., Ancoli-Israel S. Diagnostic tools for REM sleep behavior disorder. Sleep Medicine Reviews 2012, 16:415-429.
46. Patton J.H., Stanford M.S., Barratt E.S. Factor structure of the Barratt impulsiveness scale. Journal of Clinical Psychology 1995, 51:768-774.
47. Pelizza L., Ferrari A. Anhedonia in schizophrenia and major depression: state or trait?. Annals of General Psychiatry 2009, 8:22.
48. Pettorruso M., Martinotti G., Di Nicola M., Onofrij M., Conte G., Di Giannantonio M., Janiri L. Amantadine in the treatment of Pathological Gambling: a case report. Frontiers in Psychiatry 2012, 3:102. 10.3389/fpsyt.2012.00102.
49. Pontone G., Williams J.R., Bassett S.S., Marsh L. Clinical features associated with impulse control disorders in Parkinson disease. Neurology 2006, 67:1258-1261.
50. Potenza M.N. The neurobiology of pathological gambling and drug addiction: an overview and new findings. Philosophical Transactions of the Royal Society B: Biological Sciences 2008, 363:3181-3189.
51. Raja M., Bentivoglio A.R. Impulsive and compulsive behaviors during dopamine replacement treatment in Parkinson's Disease and other disorders. Current Drug Safety 2012, 7:63-75.
52. Robinson T.E., Berridge K.C. The psychology and neurobiology of addiction: an incentive-sensitization view. Addiction 2000, 95(Suppl. 2):S91-S117.
53. Santangelo G., Barone P., Trojano L., Vitale C. Pathological gambling in Parkinson's disease. A comprehensive review. Parkinsonism and Related Disorders 2013, 19:645-653.
54. Santangelo G., Morgante L., Savica R., Marconi R., Grasso L., Antonini A., De Gaspari D., Ottaviani D., Tiple D., Simoni L., Barone P. Anhedonia and cognitive impairment in Parkinson's disease: Italian validation of the Snaith-Hamilton Pleasure Scale and its application in the clinical routine practice during the PRIAMO study. Parkinsonism and Related Disorders 2009, 15:576-581. PRIAMO Study Group.
55. Santangelo G., Trojano L., Barone P., Grossi D., Vitale C. Impulse control disorders and cognitive dysfunctions in patients with Parkinson's disease. Neurological Sciences 2013, 10.1007/s10072-013-1355-3.
56. Santangelo G., Vitale C., Trojano L., Verde F., Grossi D., Barone P. Cognitive dysfunctions and pathological gambling in patients with Parkinson's disease. Movement Disorders 2009, 24:899-905.
57. Schultz W., Tremblay L., Hollerman J.R. Reward prediction in primate basal ganglia and frontal cortex. Neuropharmacology 1998, 37:421-429.
58. Siri C., Cilia R., De Gaspari D., Canesi M., Meucci N., Zecchinelli A.L., Pezzoli G., Antonini A. Cognitive status of patients with Parkinson's disease and pathological gambling. Journal of Neurology 2010, 257:247-252.
59. Snaith R.P., Hamilton M., Morley S., Humayan A., Hargreaves D., Trigwell P. A scale for the assessment of hedonic tone the Snaith-Hamilton Pleasure Scale. The British Journal of Psychiatry 1995, 167:99-103.
60. van Eimeren T., Pellecchia G., Cilia R., Ballanger B., Steeves T.D., Houle S., Miyasaki J.M., Zurowski M., Lang A.E., Strafella A.P. Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD. Neurology 2010, 75:1711-1716.
61. Vilas D., Pont-Sunyer C., Tolosa E. Impulse control disorders in Parkinson's disease. Parkinsonism and Related Disorders 2012, 18(Suppl. 1):S80-S84.
62. Vitale C., Santangelo G., Trojano L., Verde F., Rocco M., Grossi D., Barone P. Comparative neuropsychological profile of pathological gambling, hypersexuality, and compulsive eating in Parkinson's Disease. Movement Disorders 2011, 26:830-836.
63. Volkow N.D., Wang G.J., Fowler J.S., Tomasi D., Telang F. Addiction: beyond dopamine reward circuitry. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:15037-15042.
64. Voon V., Hassan K., Zurowski M., de Souza M., Thomsen T., Fox S., Lang A.E., Miyasaki J. Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology 2006, 67:1254-1257.
65. Voon V., Reynolds B., Brezing C., Gallea C., Skaljic M., Ekanayake V., Fernandez H., Potenza M.N., Dolan R.J., Hallett M. Impulsive choice and response in dopamine agonist-related impulse control behaviors. Psychopharmacology (Berl) 2010, 207:645-659.
66. Voon V., Sohr M., Lang A.E., Potenza M.N., Siderowf A.D., Whetteckey J., Weintraub D., Wunderlich G.R., Stacy M. Impulse control disorders in Parkinson disease: a multicenter case-control study. Annals of Neurology 2011, 69:986-996.
67. Voon V., Thomsen T., Miyasaki J.M., de Souza M., Shafro A., Fox S.H., Duff-Canning S., Lang A.E., Zurowski M. Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease. Archives of Neurology 2007, 64:212-216.
68. Weintraub D., Koester J., Potenza M.N., Siderowf A.D., Stacy M., Voon V., Whetteckey J., Wunderlich G.R., Lang A.E. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Archives of Neurology 2010, 67:589-595.
69. Weintraub D., Siderowf A.D., Potenza M.N., Goveas J., Morales K.H., Duda J.E., Moberg P.J., Stern M.B. Association of dopamine agonist use with impulse control disorders in Parkinson disease. Archives of Neurology 2006, 63:969-973.